Skip to main content
Top
Published in: AIDS and Behavior 4/2014

01-04-2014 | Guest Editorial

Development of Year 2020 Goals for the National HIV/AIDS Strategy for the United States

Author: David R. Holtgrave

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Abstract

In July, 2010, President Barack Obama released the National HIV/AIDS Strategy (NHAS). The NHAS set forth ambitious goals for the year 2015. These goals were potentially achievable had the appropriate level of resources been invested; however, investment at the necessary scale has not been made and the 2015 goals now may well be out of reach. Therefore, we propose that an updated NHAS be developed with goals for the year 2020 clearly articulated. For the purposes of fostering discussion on this important topic, we propose bold yet achievable quantitative 2020 goals based on previously published economic and mathematical modeling analyses.
Literature
3.
go back to reference Holtgrave DR. On the epidemiologic and economic importance of the National AIDS Strategy for the United States. J Acquir Immune Defic Syndr. 2010;55(2):139–42.PubMedCrossRef Holtgrave DR. On the epidemiologic and economic importance of the National AIDS Strategy for the United States. J Acquir Immune Defic Syndr. 2010;55(2):139–42.PubMedCrossRef
4.
go back to reference Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS Strategy in the United States: a closing window for success? AIDS Behav. 2012;16(6):1365–72.PubMedCrossRef Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS Strategy in the United States: a closing window for success? AIDS Behav. 2012;16(6):1365–72.PubMedCrossRef
9.
go back to reference Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS Behav. 2013;17(5):1632–6.PubMedCrossRef Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS Behav. 2013;17(5):1632–6.PubMedCrossRef
10.
go back to reference CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV surveillance supplemental report 2012;17(No. 3, part A):Table 5a (p. 22). CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV surveillance supplemental report 2012;17(No. 3, part A):Table 5a (p. 22).
11.
go back to reference Freedman M, Mattson C, Johnson C, et al. Medical Monitoring Project: 2009–2010. Nationally representative estimates of sexual risk behavior among HIV+adults receiving medical care: US. Presented at 19th conference on retroviruses and opportunistic infections (poster abstract 1090), Seattle, WA, 5–8 Mar 2012. Freedman M, Mattson C, Johnson C, et al. Medical Monitoring Project: 2009–2010. Nationally representative estimates of sexual risk behavior among HIV+adults receiving medical care: US. Presented at 19th conference on retroviruses and opportunistic infections (poster abstract 1090), Seattle, WA, 5–8 Mar 2012.
16.
go back to reference Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;. doi:10.1001/jamainternmed.2013.6841. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;. doi:10.​1001/​jamainternmed.​2013.​6841.
17.
go back to reference Holtgrave DR, Maulsby C, Wehrmeyer L, Hall HI. Behavioral factors in assessing impact of HIV treatment as prevention. AIDS Behav. 2012;16(5):1085–91.PubMedCrossRef Holtgrave DR, Maulsby C, Wehrmeyer L, Hall HI. Behavioral factors in assessing impact of HIV treatment as prevention. AIDS Behav. 2012;16(5):1085–91.PubMedCrossRef
20.
go back to reference Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, Holtgrave D. A systematic review of HIV interventions for black men who have sex with men (MSM). BMC Public Health. 2013;13(1):625.PubMedCentralPubMedCrossRef Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, Holtgrave D. A systematic review of HIV interventions for black men who have sex with men (MSM). BMC Public Health. 2013;13(1):625.PubMedCentralPubMedCrossRef
21.
go back to reference Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, Holtgrave D. HIV among black men who have sex with men (MSM) in the United States: a review of the literature. AIDS Behav. 2013. doi:10.1007/s10461-013-0476-2. Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, Holtgrave D. HIV among black men who have sex with men (MSM) in the United States: a review of the literature. AIDS Behav. 2013. doi:10.​1007/​s10461-013-0476-2.
22.
go back to reference Kim JJ, Positive Charge Intervention Team, Maulsby C, Kinsky S, Holtgrave D. Understanding barriers to linking persons living with HIV to care in the United States: findings from the Positive Charge Initiative. Poster presented at the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care, Washington, DC, 27 Nov 2012. Kim JJ, Positive Charge Intervention Team, Maulsby C, Kinsky S, Holtgrave D. Understanding barriers to linking persons living with HIV to care in the United States: findings from the Positive Charge Initiative. Poster presented at the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care, Washington, DC, 27 Nov 2012.
Metadata
Title
Development of Year 2020 Goals for the National HIV/AIDS Strategy for the United States
Author
David R. Holtgrave
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0579-9

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.